Blackstone’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.41M Buy
+421,701
New +$8.44M 0.02% 91

Other funds holding ADRX

Blackstone's ADRX Position: Q3 2026 in Review

Blackstone opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 421,701 shares worth $8.41M. The stake represents 0.02% of the portfolio and ranks #91 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Blackstone held 421,701 shares of ADARx Pharmaceuticals worth $8.41M as of Q3 2026.
  • ADARx Pharmaceuticals was a new Blackstone position in Q3 2026.
  • ADARx Pharmaceuticals made up 0.02% of Blackstone's portfolio in Q3 2026, its #91 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Blackstone's 13F filing for Q3 2026, filed 16 Nov 2026.